CopyMark Law Group
4.9/5
Drawing for CURAPATH

USPTO serial 97534202

CURAPATH

Reviewed by CopyMark Law Group

Reg. 7779108Status 700Registered
Filing date
Status date
Registration date
Apr 29, 2025
Examiner
HOWARD, PARKER WALDRIP
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CURAPATH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Julie R. Fenstermaker

Julie R. Fenstermaker BENESCH FRIEDLANDER COPLAN & ARONOFF LLP127 PUBLIC SQUARE, SUITE 4900CLEVELAND, OH 44114-1284United States

Goods and services

ClassDescriptionStatusFirst use
005Biopharmaceutical preparations, namely, polyamino acid based therapeutics, polymer, and lipid based pharmaceutical preparations for the treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, genetic and immune system related diseases and disordersACTIVEOct 14, 2022
040Custom manufacture of polyamino acid based and nanoparticle based biopharmaceutical preparations for purposes of scientific and medical research and for therapeutic purposesACTIVEOct 17, 2022
042Consulting services in the fields of biotechnology, pharmaceutical research and development of polyamino acid based and nanoparticle molecules for research, drug, vaccine, and therapeutic product use; product research and development for use in manufacturing of polyamino acid based and nanoparticle molecules; quality management services, namely, quality evaluation and analysis, quality assurance and quality control in the field of biotechnology and polyamino acid based and nanoparticle moleculesACTIVEOct 17, 2022
045Regulatory compliance consulting services in the biotechnology fields, namely, reviewing standards and practices and assisting third parties with compliance with governmental laws, regulations and rules pertaining to medical devices, medical technologies, medications, biopharmaceuticals, and biotechnologyACTIVEOct 17, 2022

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 29, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 29, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 7, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 7, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Apr 2, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 2, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 23, 2025IUAFUSE AMENDMENT FILED—
Jan 23, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 23, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 23, 2024EX1GSOU EXTENSION 1 GRANTED—
Aug 23, 2024EXT1SOU EXTENSION 1 FILED—
Aug 23, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 27, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 2, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 2, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 13, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 27, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 20, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 20, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 20, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 18, 2023XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Aug 18, 2023XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
May 25, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 25, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 25, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 23, 2023DOCKASSIGNED TO EXAMINER—
Aug 25, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 8, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance